• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Cowen (Group)

Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm that operates through two business segments: a broker dealer and an investment management division. The Company’s broker dealer division offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing and commission management services. Cowen’s investment management segment offers actively managed alternative investment products. Cowen Inc. focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the firm is headquartered in New York and has offices worldwide. *

 

	Start	2012-06-10 existent
	Industry	finance
	Industry 2	investment banking
	Region	New York, NY
	Country	United States (USA)
	Street	599 Lexington Avenue
	City	10022 New York, NY
	Tel	+1-646-562-1000
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for �About Section�: Cowen Inc.. (2/22/21). "Press Release: Adam Chazan Joins Cowen’s Health Care Investment Banking Team". New York, NY.
		Record changed: 2021-12-28

Advertisement

More documents for Cowen (Group)

• [1] Compass Pathways plc. (4/30/21). "Press Release: Compass Pathways Announces Pricing of Public Offering". London....
• [2] Compass Pathways plc. (4/27/21). "Press Release: Compass Pathways Launches Proposed Public Offering". London....
• [3] VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel....
• [4] Argenx SE. (5/29/20). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent....
• [5] Argenx SE. (5/28/20). "Press Release: Argenx Raises $750 Million in Gross Proceeds in a Global Offering". Breda & Ghent....
• [6] Oxford Nanopore Technologies Ltd.. (5/26/20). "Press Release: Oxford Nanopore Announces £48.4M ($59.2M) in New Capital to Support Ongoing Innovation and the Rapid Worldwide Growth of Nanopore Sequencing". Oxford....
• [7] AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht....
• [8] Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA....
• [9] Orchard Therapeutics Ltd.. (3/4/19). "Press Release: Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019". Boston, MA & London....
• [10] Argenx SE. (3/4/19). "Press Release: Argenx to Present at Cowen and Company 39th Annual Health Care Conference". Breda & Ghent....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.